Search research articles
Contact Us
Filters
Showing results (11-20 of 45) with videos related to
Page
of 5
Sort By:
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery
|
June 6, 2007
Relationship of botulinum dosage to duration of side effects and normal voice in adductor spasmodic dysphonia
Christopher Y Chang, Peter Chabot, James P Thomas
Journal of Endodontics
|
February 11, 2020
Micro-computed Tomographic Evaluation of the Shaping Ability of WaveOne Gold, TRUShape, EdgeCoil, and XP-3D Shaper Endodontic Files in Single, Oval-shaped Canals: An In Vitro Study
James P Thomas, Michelle Lynch, Susan Paurazas, et al.
Experimental Brain Research
|
March 10, 2006
Effects of nonspatial selective and divided visual attention on fMRI BOLD responses
Riklef Weerda, Ignacio Vallines, James P Thomas, et al.
The Laryngoscope
|
December 28, 2022
Diagnosis and Management of Vocal Complications after Chondrolaryngoplasty
Brian Nuyen, Z Jason Qian, Meher Rakkar, et al.
International Journal of Gastrointestinal Cancer
|
June 10, 2003
Phase II trial of perillyl alcohol in patients with metastatic colorectal cancer
Sherry Morgan Meadows, Daniel Mulkerin, Jordan Berlin, et al.
Annals of Surgical Oncology
|
October 12, 2013
Review of the impact of antineoplastic therapies on the risk for cholelithiasis and acute cholecystitis
Thejus T Jayakrishnan, Ryan T Groeschl, Ben George, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 1, 2002
Phase III study of gemcitabine in combination with fluorouracil versus gemcitabine alone in patients with advanced pancreatic carcinoma: Eastern Cooperative Oncology Group Trial E2297
Jordan D Berlin, Paul Catalano, James P Thomas, et al.
Oncology
|
March 25, 2009
Fixed-dose-rate gemcitabine in combination with oxaliplatin in patients with metastatic pancreatic cancer refractory to standard-dose-rate gemcitabine: a single-institute study
Brett E Fortune, Xiaobai Li, Kavitha V Kosuri, et al.
Surgical Endoscopy
|
April 2, 2014
Management of acute cholecystitis in cancer patients: a comparative effectiveness approach
Thejus T Jayakrishnan, Ryan T Groeschl, Ben George, et al.
Investigational New Drugs
|
December 10, 2009
Phase I trial of motexafin gadolinium and doxorubicin in the treatment of advanced malignancies
Anne M Traynor, James P Thomas, Ramesh K Ramanathan, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 45) with videos related to
Sort By:
Page
of 5
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery
|
June 6, 2007
Relationship of botulinum dosage to duration of side effects and normal voice in adductor spasmodic dysphonia
Christopher Y Chang, Peter Chabot, James P Thomas
Journal of Endodontics
|
February 11, 2020
Micro-computed Tomographic Evaluation of the Shaping Ability of WaveOne Gold, TRUShape, EdgeCoil, and XP-3D Shaper Endodontic Files in Single, Oval-shaped Canals: An In Vitro Study
James P Thomas, Michelle Lynch, Susan Paurazas, et al.
Experimental Brain Research
|
March 10, 2006
Effects of nonspatial selective and divided visual attention on fMRI BOLD responses
Riklef Weerda, Ignacio Vallines, James P Thomas, et al.
The Laryngoscope
|
December 28, 2022
Diagnosis and Management of Vocal Complications after Chondrolaryngoplasty
Brian Nuyen, Z Jason Qian, Meher Rakkar, et al.
International Journal of Gastrointestinal Cancer
|
June 10, 2003
Phase II trial of perillyl alcohol in patients with metastatic colorectal cancer
Sherry Morgan Meadows, Daniel Mulkerin, Jordan Berlin, et al.
Annals of Surgical Oncology
|
October 12, 2013
Review of the impact of antineoplastic therapies on the risk for cholelithiasis and acute cholecystitis
Thejus T Jayakrishnan, Ryan T Groeschl, Ben George, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 1, 2002
Phase III study of gemcitabine in combination with fluorouracil versus gemcitabine alone in patients with advanced pancreatic carcinoma: Eastern Cooperative Oncology Group Trial E2297
Jordan D Berlin, Paul Catalano, James P Thomas, et al.
Oncology
|
March 25, 2009
Fixed-dose-rate gemcitabine in combination with oxaliplatin in patients with metastatic pancreatic cancer refractory to standard-dose-rate gemcitabine: a single-institute study
Brett E Fortune, Xiaobai Li, Kavitha V Kosuri, et al.
Surgical Endoscopy
|
April 2, 2014
Management of acute cholecystitis in cancer patients: a comparative effectiveness approach
Thejus T Jayakrishnan, Ryan T Groeschl, Ben George, et al.
Investigational New Drugs
|
December 10, 2009
Phase I trial of motexafin gadolinium and doxorubicin in the treatment of advanced malignancies
Anne M Traynor, James P Thomas, Ramesh K Ramanathan, et al.
Page
of 5